Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Ward

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Biochimica Et Biophysica Acta|October 7, 1988
Fluorescent glucagon derivatives. I. Synthesis and characterisation of fluorescent glucagon derivativesH Heithier, L D Ward, R C Cantrill, et al.
FEBS Letters|February 25, 1991
Cloning and sequencing of Lol pI, the major allergenic protein of rye-grass pollenI J Griffith, P M Smith, J Pollock, et al.
Human Vaccines|March 15, 2008
Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapyS Emery, A D Kelleher, C Workman, et al.
Human Vaccines|October 3, 2006
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjectsS Emery, C Workman, R L Puls, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Biochimica Et Biophysica Acta|October 7, 1988
Fluorescent glucagon derivatives. I. Synthesis and characterisation of fluorescent glucagon derivativesH Heithier, L D Ward, R C Cantrill, et al.
FEBS Letters|February 25, 1991
Cloning and sequencing of Lol pI, the major allergenic protein of rye-grass pollenI J Griffith, P M Smith, J Pollock, et al.
Human Vaccines|March 15, 2008
Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapyS Emery, A D Kelleher, C Workman, et al.
Human Vaccines|October 3, 2006
Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjectsS Emery, C Workman, R L Puls, et al.
Pageof 6